Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Ella Foundation of Bharat Biotech has successfully tested a preliminary vaccine for Ebola on mice. Ella Foundation has been trying to discover a suitable vaccine to check the deadly viral disease that shook the world recently. Vaccine from adenovirus and glycoprotein was tested on mice and the good results were found to be  for developing a full-fledged vaccine. Adenoviruses are accountable for respiratory infections, gastroenteritis, cystitis, and primary pneumonia in humans, and are used as a clear target to understand the human immunity characteristics in laboratory. However, the efficacy of the vaccine will be evaluated by the results seen in human trials.

    Ebola, previously known as Ebola hemorrhagic fever, is a rare and deadly disease caused by infection with one of the Ebola virus strain. Ebola is a multi-organ infecting disease. The virus could spread fast through human touch. Particularly India needs to be vigilant in containing this disease. Having understood the gravity of the situation across the world due to this disease the efforts of Bharat Biotech and its foundation are hailed all over.  It has not yet hit India. The worst hit part of the world is Africa.

    Other major companies that are working to provide a fool proof vaccine solution to Ebola in the world are GlaxoSmitKline, Johnson & Johnson, Merck and Novavax. All these companies combined have invested an amount of approximately 500 million towards research and development of this vaccine.

    << Pharma News

    Subscribe to PharmaTutor News Alerts by Email >>

  • Despite mutating, the ebola virus has not evolved to become deadlier since the first outbreak 40 years ago, scientists say. The findings suggest that the much higher death toll during the current outbreak, with the figure at nearly 10,500, is not due to mutations making the virus more deadly or more virulent.

  • Researchers have developed a quick-acting Ebola vaccine that is both safe and effective with a single dose against the strain of the virus that killed thousands of people in West Africa last year. “These findings may pave the way for the identification and manufacture of safer, single dose, high efficiency vaccines to combat current and future Ebola outbreaks,” said Thomas Geisbert, from the University of Texas Medical Branch at Galveston.

  • (Business Wire India); Teva Pharmaceutical Industries Ltd. has announced that an updated investor presentation in connection with its proposed combination with Mylan N.V. is available on the Investor Relations section of the Company’s website and will be filed with the Securities and Exchange Commission (“SEC”).

  • 6 May 2015
    Breast cancer vaccines and silicon microparticles together may work better

    The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports (early online).

  • The European Commission has granted marketing authorization in Europe for Sanofi's Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus in adults. Its significant milestone for Sanofi. This gives people with diabetes and their physicians a new option to manage their condition.

  • aTyr Pharma, a biotherapeutics company engaged in the discovery and development of physiocrine-based therapeutics to address rare diseases, announced  that Resolaris has been granted Orphan Drug designation by the US Food and Drug Administration (FDA) for the treatment of facioscapulohumeral muscular dystrophy (FSHD).  Resolaris, an investigational new drug,  is being developed as a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune component.

  • Women glow during pregnancy because they share the blood of their young foetus which has a rejuvenating effect on the mother which regenerates tissue and slow down the ageing process, according to a report. The oft-used phrase “pregnancy glow” seems to now have some basis in science because pregnancy helps regenerate tissue and slow down the ageing process. The effect occurs because of the shared blood between mother and child.

  • The government gave its approval for signing of an agreement with Mauritius on cooperation in traditional medicine systems and homoepathy. In a meeting, the Union cabinet chaired by Prime Minister Narendra Modi gave its approval for the memorandum of understanding between the two countries to enhance bilateral cooperation in areas of traditional medicine including medicinal plants, Telecom Minister Ravi Shankar Prasad said told reporters.

  • Three Indian pharmaceutical companies, namely Alembic Pharmaceuticals, Hetero Labs and Torrent Pharmaceuticals have get the US Food and Drug Administration (FDA) approval for generic versions of Abilify (aripiprazole). Aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and bipolar disorder.   Teva Pharmaceuticals has also get  similar approval.

     

    [adsense:336x280:8701650588]

Subscribe to Pharma News